Cargando…

Rapid anti‐depressant‐like effects of ketamine and other candidates: Molecular and cellular mechanisms

Major depressive disorder takes at least 3 weeks for clinical anti‐depressants, such as serotonin selective reuptake inhibitors, to take effect, and only one‐third of patients remit. Ketamine, a kind of anaesthetic, can alleviate symptoms of major depressive disorder patients in a short time and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Fan Zhen, Fan, Jie, Ge, Tong Tong, Liu, Qian Qian, Li, Bing Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260066/ https://www.ncbi.nlm.nih.gov/pubmed/32266752 http://dx.doi.org/10.1111/cpr.12804

Ejemplares similares

Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
por: Wohleb, Eric S., et al.
Publicado: (2017)

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
por: Hashimoto, Kenji
Publicado: (2019)

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012)

Rapid Response with Ketamine on Suicidal Cognition in Resistant Depression
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012)

Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice
por: Rawat, Radhika, et al.
Publicado: (2022)

(S)-Ketamine but Not (R)-Ketamine Shows Acute Effects on Depression-Like Behavior and Sleep-Wake Architecture in Rats
por: Koncz, Szabolcs, et al.
Publicado: (2023)

The interactive effects of ketamine and magnesium upon depressive-like pathology
por: Razmjou, Sara, et al.
Publicado: (2016)

Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review
por: Song, Bijia, et al.
Publicado: (2021)

GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
por: Miller, Oliver H, et al.
Publicado: (2014)

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Nikkheslat, Naghmeh
Publicado: (2021)

The Regulation of Glutamate Transporter 1 in the Rapid Antidepressant-Like Effect of Ketamine in Mice
por: Chen, Yaping, et al.
Publicado: (2022)

Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
por: Yang, Chun, et al.
Publicado: (2019)

Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
por: Qu, Youge, et al.
Publicado: (2017)

Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
por: Borentain, Stephane, et al.
Publicado: (2022)

Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression
por: Ponton, Ethan, et al.
Publicado: (2021)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
por: Duman, Ronald S.
Publicado: (2018)

S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression
por: Ardalan, Maryam, et al.
Publicado: (2016)

Enhanced TARP-γ8-PSD-95 coupling in excitatory neurons contributes to the rapid antidepressant-like action of ketamine in male mice
por: Xue, Shi-Ge, et al.
Publicado: (2023)

Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers
por: Kruse, Jennifer L., et al.
Publicado: (2021)

Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
por: Ficek, Joanna, et al.
Publicado: (2016)

Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
por: Yang, Bangkun, et al.
Publicado: (2016)

How ketamine helps to overcome depression
por: Huynh, Thu N, et al.
Publicado: (2014)

Ketamine and depression: a narrative review
por: Corriger, Alexandrine, et al.
Publicado: (2019)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Efficacy of ketamine therapy in the treatment of depression
por: Mandal, Suprio, et al.
Publicado: (2019)

The effect of ketamine on preventing postpartum depression
por: Alipoor, Mina, et al.
Publicado: (2021)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
por: Lally, N, et al.
Publicado: (2014)

Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
por: Cathomas, Flurin, et al.
Publicado: (2022)

Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
por: Kopelman, Jared, et al.
Publicado: (2023)

Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure
por: Li, Su-Xia, et al.
Publicado: (2014)

Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder
por: Anderson, Kevin M., et al.
Publicado: (2020)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

TIAM1-mediated synaptic plasticity underlies comorbid depression–like and ketamine antidepressant–like actions in chronic pain
por: Ru, Qin, et al.
Publicado: (2022)

Safety of Repeated Administration of Parenteral Ketamine for Depression
por: Feifel, David, et al.
Publicado: (2020)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Subcutaneous Ketamine in Depression: A Systematic Review
por: Cavenaghi, Vitor Breseghello, et al.
Publicado: (2021)

Ketamine for Bipolar Depression: A Systematic Review
por: Bahji, Anees, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fh6edm1f29j9nl6fr6tojccsps